Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy Wedbush

Biocryst Pharmaceuticals
Start price
€7.43
07.05.26 / 50%
Target price
€17.86
07.05.27
Performance (%)
23.12%
Price
€9.15
10.07.26
Summary
This prediction is currently active. The prediction currently has a performance of 23.12%. This prediction currently runs until 07.05.27. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Biocryst Pharmaceuticals 8.973% 8.973%
iShares Core DAX® -1.779% 2.475%
iShares Nasdaq 100 1.522% 3.290%
iShares Nikkei 225® 1.083% 7.039%
iShares S&P 500 0.929% 3.254%

Comments by Wedbush for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 23.12%
Target price 17.863
Change
Ends at 07.05.27

BioCryst Pharmaceuticals (BCRX) had its price target lowered by Wedbush from $22.00 to $21.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat

Wedbush 
0
Report Share
07.05.26

Stopped prediction by Wedbush for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€7.60
30.06.25
€15.36
30.06.26
14.00%
01.07.26

Wedbush 
30.06.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€7.80
25.02.25
€14.28
25.02.26
-19.22%
26.02.26

Wedbush 
25.02.25 50%